2024年至2032年兽医立体定位放射外科系统市场机会、成长动力、产业趋势分析与预测

2023 年，全球兽医立体定位放射外科系统市场价值为 4.123 亿美元，预计 2024 年至 2032 年复合年增长率为 9.3%。诊断和治疗技术的创新，例如人工智慧驱动的系统和先进的放射疗法，提高了兽医肿瘤学的精确度和有效性。这推动了对先进系统的需求。宠物主人和兽医诊所寻求癌症管理的创新解决方案，刺激了对专业设备和服务的需求。

市场分为线性加速器（直线加速器）、射波刀和伽马刀。 2023 年，直线加速器部门的收入为 1.993 亿美元。直线加速器系统擅长为各种肿瘤（包括脑肿瘤和脊椎肿瘤）提供标靶放射治疗。先进的影像和治疗功能使直线加速器系统成为各种兽医肿瘤学应用的理想选择。

在经过验证的有效性和持续的技术进步的推动下，它们在兽医医院和专科诊所中得到广泛采用，巩固了直线加速器领域在市场上的领先地位。根据应用，兽医立体定位放射手术系统市场分为脑肿瘤、脊椎肿瘤和其他应用。 2023 年，脑肿瘤细分市场占据 59% 的主导市场份额，预计这一趋势将在整个分析期间持续存在。利用立体定位放射外科系统治疗这些肿瘤可确保精确、非侵入性的治疗方法，从而显着减少对邻近健康组织的伤害。

兽医实务中脑肿瘤的高发生率凸显了对专门用于治疗这些肿瘤的先进立体定位放射手术技术的需求。 2023年，美国以1.52亿美元的估值引领北美兽医立体定位放射外科系统市场。美国的主导地位源自于其最先进的兽医医疗基础设施和对创新技术的迅速采用。美国许多专业兽医医院和研究机构利用立体定位放射外科系统来解决宠物的复杂癌症病例。

主要技术提供者的存在和兽医肿瘤学领域的持续创新巩固了美国市场的领导地位。高宠物拥有率和投资先进治疗的意愿进一步推动了这项需求。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 增加动物数量和拥有率
    • 动物癌症发生率上升
    • 癌症诊断和治疗技术的进步
    • 提高早期诊断和治疗意识
  • 产业陷阱与挑战
    • 治疗费用高
    • 立体定位放射外科系统的稀缺
    • 严格的监管标准和审批程序
• 成长潜力分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

• 主要趋势
• 直线加速器（Linac）
• 射波刀
• 伽玛刀

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 脑肿瘤
• 脊椎肿瘤
• 其他应用

第 7 章：市场估计与预测：按最终用户划分，2021 - 2032 年

• 主要趋势
• 兽医院
• 兽医诊所
• 其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Accuray Incorporated
• Elekta AB
• Varian Medical Systems

The Global Veterinary Stereotactic Radiosurgery System Market was valued at USD 412.3 million in 2023 and is projected to grow at a CAGR of 9.3% from 2024 to 2032. Drivers include the increasing focus on advancing cancer care and research for animals. Innovations in diagnostic and treatment technologies, such as AI-driven systems and advanced radiation therapies, enhance the precision and effectiveness of veterinary oncology. This propels the demand for advanced systems. Pet owners and veterinary practices seek innovative solutions for cancer management, fueling the demand for specialized equipment and services.

The market is segmented into linear accelerators (Linac), CyberKnife, and gamma knife. In 2023, the Linac segment generated revenue of USD 199.3 million. Linac systems excel in delivering targeted radiation therapy for various tumors, including brain and spinal tumors. Advanced imaging and treatment capabilities make Linac systems ideal for a wide range of veterinary oncology applications.

Their widespread adoption in veterinary hospitals and specialty clinics, driven by proven effectiveness and ongoing technological advancements, solidifies the Linac segment's top position in the market. Based on application, the veterinary stereotactic radiosurgery system market is categorized into brain tumors, spinal tumors, and other applications. In 2023, the brain tumors segment commanded a dominant market share of 59%, a trend anticipated to persist throughout the analysis period. Utilizing the stereotactic radiosurgery system for these tumors ensures a precise, non-invasive treatment approach, significantly reducing harm to adjacent healthy tissues.

The high incidence of brain tumors in veterinary practices underscores the demand for advanced stereotactic radiosurgery technologies, tailored specifically for managing these tumors. In 2023, the U.S. led the North American veterinary stereotactic radiosurgery system market with a valuation of USD 152 million. The U.S. dominance stems from its state-of-the-art veterinary healthcare infrastructure and a swift embrace of innovative technologies. Numerous specialized veterinary hospitals and research institutions in the U.S. leverage stereotactic radiosurgery systems to address intricate cancer cases in pets.

The presence of major technology providers and ongoing innovations in veterinary oncology bolster the U.S. market leadership. High rates of pet ownership and a readiness to invest in advanced treatments further fuel this demand.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing animal population and ownership rates
    • 3.2.1.2 Rising cancer incidences among animals
    • 3.2.1.3 Advancements in technology for diagnosing and treating cancer
    • 3.2.1.4 Heightened awareness regarding early diagnosis and treatment
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High treatment costs
    • 3.2.2.2 Scarcity of stereotactic radiosurgery systems
    • 3.2.2.3 Stringent regulatory standards and approval procedures
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Linear accelerators (Linac)
• 5.3 CyberKnife
• 5.4 Gamma knife

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Brain tumors
• 6.3 Spinal tumors
• 6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Veterinary hospitals
• 7.3 Veterinary clinics
• 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Accuray Incorporated
• 9.2 Elekta AB
• 9.3 Varian Medical Systems